US FDA approves Shingrix to prevent shingles in immuno-compromised adults
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.